rank,protein_id,score,known_target,gnn_predicted_outcomes,associated_adverse_effects,reasoning
1,RET - ret proto-oncogene (human),1.0,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> RET - ret proto-oncogene (human) (evidence: 0.3 nM (IC50 (AID: 1934929; 0.3 nM (IC50 (AID: 1895756; 0.4 nM (IC50 (AID: 1934930). Path 2: No (RET - ret proto-oncogene (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
2,RET,1.0,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> RET (evidence: Active nan (Proto-oncogene c-Ret (RET; Active nan (ret proto-oncogene; Active nan (RET). Path 2: No (RET, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
3,KIF5B - kinesin family member 5B (human),0.99999737739563,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung","Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Renal Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Genital Neoplasms, Male | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Radiation-Induced | Neovascularization, Pathologic | Nerve Sheath Neoplasms | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KIF5B - kinesin family member 5B (human) (evidence: 4.0 nM (GI50 (AID: 1704858; 4.0 nM (GI50 (AID: 1704862; 5.0 nM (IC50 (AID: 1895764). Path 2: KIF5B - kinesin family member 5B (human) --[associated_with]--> Abdominal Neoplasms | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Papillary | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Insufficiency ... (+204 more)."
4,EML4,0.9999957084655762,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, EML4) edge in KG; GNN predicts link (score=1.0000). Path 2: No (EML4, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
5,KIF5B,0.999987006187439,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> KIF5B (evidence: Active nan (KIF5B). Path 2: No (KIF5B, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
6,PTK2B,0.9999868869781494,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> PTK2B (evidence: Active nan (PTK2B). Path 2: No (PTK2B, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
7,CCDC6 - coiled-coil domain containing 6 (human),0.9999831914901732,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung","Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brain Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypopharyngeal Neoplasms | Hypothyroidism | Hypothyroidism, Autoimmune | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, Radiation-Induced | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Mesothelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Paraquat lung | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Salivary Gland Neoplasms | Sigmoid Neoplasms | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> CCDC6 - coiled-coil domain containing 6 (human) (evidence: 0.4 nM (IC50 (AID: 1895760; 4.0 nM (GI50 (AID: 1704857). Path 2: CCDC6 - coiled-coil domain containing 6 (human) --[associated_with]--> Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic ... (+222 more)."
8,CCDC6,0.9999428987503052,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> CCDC6 (evidence: Active nan (CCDC6). Path 2: No (CCDC6, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
9,DRD2,0.999942660331726,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> DRD2 (evidence: Active nan (DRD2). Path 2: No (DRD2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
10,KDR,0.999942421913147,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> KDR (evidence: Active nan (kinase insert domain receptor). Path 2: No (KDR, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
11,KDR - kinase insert domain receptor (human),0.99980491399765,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung","Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Diamond-Blackfan | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Signet Ring Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardio-Renal Syndrome | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebellar Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Diabetes Mellitus, Congenital Autoimmune | Disseminated Intravascular Coagulation | Duodenal Neoplasms | Ear Neoplasms | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Eye Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastro-enteropancreatic neuroendocrine tumor | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hepatorenal Syndrome | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypothyroidism | IMMUNE SUPPRESSION | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Kidney disorder involving deposition of calcium and oxalate or phosphate in the renal tubules | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia P388 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Hairy Cell | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | Leukemia, Myelomonocytic, Chronic | Leukemia, Myelomonocytic, Juvenile | Leukemia, Plasma Cell | Leukemia, Prolymphocytic, T-Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Fungal | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Primary Effusion | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Mesothelial | Neoplasms, Multiple Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuroectodermal Tumor, Melanotic | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Parotid Neoplasms | Peripheral Vascular Diseases | Peritoneal Neoplasms | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sigmoid Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Neoplasms | Thymus Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Thyroiditis | Thyroiditis, Autoimmune | Tongue Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> KDR - kinase insert domain receptor (human) (evidence: 35.0 nM (IC50 (AID: 1895759). Path 2: KDR - kinase insert domain receptor (human) --[associated_with]--> Abdominal Neoplasms | Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms ... (+268 more)."
12,FLT3 - fms related receptor tyrosine kinase 3 (human),0.99980229139328,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung","Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Refractory, with Excess of Blasts | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Bone Marrow Neoplasms | Brain Neoplasms | Brain Stem Neoplasms | Breast Neoplasms | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoma | Carcinoma in Situ | Carcinoma, Bronchogenic | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Intrahepatic | Choriocarcinoma | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia, Experimental | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myeloid, Chronic-Phase | Leukemia, Myelomonocytic, Chronic | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Large-Cell, Anaplastic | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Experimental | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neovascularization, Pathologic | Neuroectodermal Tumors | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Prostatic Neoplasms | Pseudotumor Cerebri | Rectal Neoplasms | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Neoplasms | Small Cell Lung Carcinoma | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Malformations | Vascular Remodeling | Vascular System Injuries | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> FLT3 - fms related receptor tyrosine kinase 3 (human) (evidence: 6.5 nM (IC50 (AID: 1776973). Path 2: FLT3 - fms related receptor tyrosine kinase 3 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Acute erythroleukemia | Adenocarcinoma | Adenocarcinoma of Lung | Adrenal Cortex Diseases | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency ... (+194 more)."
13,Tyrosine-protein kinase JAK2 (human),0.9997957348823548,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung","Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases | Adrenal Gland Neoplasms | Adrenal Hyperplasia, Congenital | Adrenal Insufficiency | Adrenocortical Carcinoma | Anemia | Anemia, Aplastic | Anemia, Hemolytic | Anemia, Hemolytic, Autoimmune | Anemia, Hypochromic | Anemia, Iron-Deficiency | Anemia, Macrocytic | Anemia, Megaloblastic | Anemia, Refractory, with Excess of Blasts | Anemia, Sickle Cell | Anemia, Sideroblastic | Anus Neoplasms | Arrhythmias, Cardiac | Autoimmune Diseases | Basal Cell Carcinoma | Basal Ganglia Cerebrovascular Disease | Bone Marrow Neoplasms | Bone Neoplasms | Brachydactyly with hypertension | Brain Neoplasms | Breast Neoplasms | Breast Neoplasms, Male | Bronchial Neoplasms | Burkitt Lymphoma | Carcinoid Tumor | Carcinoma | Carcinoma in Situ | Carcinoma, Adenosquamous | Carcinoma, Bronchogenic | Carcinoma, Ductal | Carcinoma, Ductal, Breast | Carcinoma, Ehrlich Tumor | Carcinoma, Embryonal | Carcinoma, Endometrioid | Carcinoma, Hepatocellular | Carcinoma, Islet Cell | Carcinoma, Large Cell | Carcinoma, Lewis Lung | Carcinoma, Lobular | Carcinoma, Merkel Cell | Carcinoma, Non-Small-Cell Lung | Carcinoma, Ovarian Epithelial | Carcinoma, Pancreatic Ductal | Carcinoma, Papillary | Carcinoma, Renal Cell | Carcinoma, Small Cell | Carcinoma, Squamous Cell | Carcinoma, Transitional Cell | Cardiac Complexes, Premature | Cardiac Conduction System Disease | Cardiac Output, High | Cardiac Output, Low | Cardiac Tamponade | Cardiovascular Abnormalities | Cardiovascular Diseases | Central Nervous System Neoplasms | Cerebrovascular Disorders | Cholangiocarcinoma | Cholestasis, Extrahepatic | Cholestasis, Intrahepatic | Cholestasis, progressive familial intrahepatic 3 | Choriocarcinoma | Choroidal Neovascularization | Clear-cell metastatic renal cell carcinoma | Colitis-Associated Neoplasms | Colonic Neoplasms | Colorectal Neoplasms | Congenital Hypothyroidism | Conotruncal cardiac defects | Corneal Neovascularization | Cystadenocarcinoma | Death, Sudden, Cardiac | Dementia, Vascular | Desmoid Tumors | Desmoplastic Small Round Cell Tumor | Disseminated Intravascular Coagulation | Edema, Cardiac | Encephalomyelitis, Autoimmune, Experimental | Endocrine Gland Neoplasms | Endometrial Neoplasms | Esophageal Neoplasms | Esophageal Squamous Cell Carcinoma | Essential Hypertension | Euthyroid Sick Syndromes | Fallopian Tube Neoplasms | Familial primary gastric lymphoma | Fanconi Anemia | Gallbladder Neoplasms | Gastrointestinal Neoplasms | Gastrointestinal Stromal Tumors | Genital Neoplasms, Female | Genital Neoplasms, Male | Giant Cell Tumor of Bone | Glycosuria, Renal | Granulosa cell tumor of the ovary | Head and Neck Neoplasms | Hematologic Neoplasms | Hepatic Encephalopathy | Hepatic Insufficiency | Hepatic Veno-Occlusive Disease | Hepatitis, Autoimmune | Hypertension | Hypertension, Malignant | Hypertension, Portal | Hypertension, Pregnancy-Induced | Hypertension, Pulmonary | Hypertension, Renal | Hypertension, Renovascular | Hyperthyroidism | Hypomagnesemia 2, renal | Hypothyroidism | IMMUNE SUPPRESSION | Idiopathic intracranial hypertension with papilledema | Immune Complex Diseases | Immune System Diseases | Inflammatory Breast Neoplasms | Intestinal Neoplasms | Intracranial Hypertension | Kidney Neoplasms | Laryngeal Neoplasms | Leukemia | Leukemia L1210 | Leukemia, Erythroblastic, Acute | Leukemia, Experimental | Leukemia, Large Granular Lymphocytic | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Lymphoid | Leukemia, Monocytic, Acute | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Leukemia, Myeloid | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Acute | Leukemia, Myelomonocytic, Chronic | Leukemia, Plasma Cell | Leukemia, Promyelocytic, Acute | Leukemia, T-Cell | Leukemia-Lymphoma, Adult T-Cell | Leydig Cell Tumor | Liver Neoplasms | Liver Neoplasms, Experimental | Lung Diseases | Lung Diseases, Interstitial | Lung Diseases, Obstructive | Lung Diseases, Parasitic | Lung Injury | Lung Neoplasms | Lung agenesis | Lymphatic Metastasis | Lymphoma | Lymphoma, AIDS-Related | Lymphoma, B-Cell | Lymphoma, Extranodal NK-T-Cell | Lymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-Cell | Lymphoma, Non-Hodgkin | Lymphoma, T-Cell | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Male Germ Cell Tumor | Mammary Neoplasms, Animal | Mammary Neoplasms, Experimental | Massive Hepatic Necrosis | Maxillary Sinus Neoplasms | Meningeal Carcinomatosis | Mesenteric Vascular Occlusion | Mixed Tumor, Mullerian | Mouth Neoplasms | Nasopharyngeal Carcinoma | Nasopharyngeal Neoplasms | Neoplasm Invasiveness | Neoplasm Metastasis | Neoplasm Micrometastasis | Neoplasm Recurrence, Local | Neoplasms | Neoplasms, Bone Tissue | Neoplasms, Experimental | Neoplasms, Fibrous Tissue | Neoplasms, Germ Cell and Embryonal | Neoplasms, Glandular and Epithelial | Neoplasms, Hormone-Dependent | Neoplasms, Radiation-Induced | Neoplasms, Second Primary | Neoplasms, Squamous Cell | Neoplasms, Unknown Primary | Neovascularization, Pathologic | Nervous System Neoplasms | Neuritis, Autoimmune, Experimental | Neuroectodermal Tumors | Neuroectodermal Tumors, Primitive | Neuroectodermal Tumors, Primitive, Peripheral | Neuroendocrine Tumors | Neutropenia | Nonseminomatous germ cell tumor | Nose Neoplasms | Ocular Hypertension | Ovarian Neoplasms | Pancreatic Neoplasms | Pancreatic cancer, adult | Paraganglioma, Extra-Adrenal | Peripheral Vascular Diseases | Pharyngeal Neoplasms | Phyllodes Tumor | Pituitary Neoplasms | Pleural Neoplasms | Porphyrias, Hepatic | Precancerous Conditions | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | Pregnancy Complications, Cardiovascular | Prostatic Neoplasms | Pseudolymphoma | Pseudotumor Cerebri | Pulmonary Arterial Hypertension | Rectal Neoplasms | Renal Aminoacidurias | Renal Artery Obstruction | Renal Insufficiency | Renal Insufficiency, Chronic | Renal hypouricemia | Retinal Neovascularization | Salivary Gland Neoplasms | Sebaceous Gland Neoplasms | Sinus Arrest, Cardiac | Skin Diseases, Vascular | Skin Neoplasms | Small Cell Lung Carcinoma | Soft Tissue Neoplasms | Splenic Neoplasms | Squamous Cell Carcinoma of Head and Neck | Stomach Neoplasms | Testicular Germ Cell Tumor | Testicular Neoplasms | Thyroid Cancer, Papillary | Thyroid Diseases | Thyroid Dysgenesis | Thyroid Hormone Metabolism, Abnormal | Thyroid Neoplasms | Thyroid cancer, follicular | Thyroid cancer, medullary | Tongue Neoplasms | Tracheal Neoplasms | Triple Negative Breast Neoplasms | Tumor Lysis Syndrome | Ureteral Neoplasms | Urethral Neoplasms | Urinary Bladder Neoplasms | Urogenital Neoplasms | Urologic Neoplasms | Uterine Cervical Neoplasms | Uterine Neoplasms | Uveal Neoplasms | Vaginal Neoplasms | Vascular Calcification | Vascular Diseases | Vascular Headaches | Vascular Malformations | Vascular Neoplasms | Vascular Remodeling | Vascular System Injuries | Vulvar Neoplasms | Wilms Tumor","Path 1: Pralsetinib --[inhibits]--> Tyrosine-protein kinase JAK2 (human) (evidence: 2.0 nM (IC50 (AID: 1776972). Path 2: Tyrosine-protein kinase JAK2 (human) --[associated_with]--> Acidosis, Renal Tubular | Acute Lung Injury | Adenocarcinoma | Adenocarcinoma of Lung | Adenocarcinoma, Bronchiolo-Alveolar | Adenocarcinoma, Clear Cell | Adenocarcinoma, Mucinous | Adrenal Cortex Diseases | Adrenal Cortex Neoplasms | Adrenal Gland Diseases ... (+267 more)."
14,Proto-oncogene tyrosine-protein kinase receptor Ret (human),0.9997918009757996,True,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: Pralsetinib --[inhibits]--> Proto-oncogene tyrosine-protein kinase receptor Ret (human) (evidence: 0.4 nM (IC50 (AID: 2091116). Path 2: No (Proto-oncogene tyrosine-protein kinase receptor Ret (human), associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
15,HRAS,0.0016718092374503,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, HRAS) edge in KG; GNN predicts link (score=0.0017). Path 2: No (HRAS, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
16,KIF11,0.0014356872998178,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, KIF11) edge in KG; GNN predicts link (score=0.0014). Path 2: No (KIF11, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
17,HNRNPF,0.0005351621657609,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, HNRNPF) edge in KG; GNN predicts link (score=0.0005). Path 2: No (HNRNPF, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
18,NEK3,0.0002003228437388,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, NEK3) edge in KG; GNN predicts link (score=0.0002). Path 2: No (NEK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
19,CCNH,7.815581193426624e-05,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, CCNH) edge in KG; GNN predicts link (score=0.0001). Path 2: No (CCNH, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
20,LUM,2.948951987491455e-05,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, LUM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LUM, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
21,PRKX,1.111550045607146e-05,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, PRKX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRKX, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
22,BMX,4.349042683315929e-06,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, BMX) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BMX, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
23,CLCN6,1.7664611959844478e-06,False,"Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, CLCN6) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLCN6, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Anemia | Thyroid Neoplasms | Neutropenia | Carcinoma, Non-Small-Cell Lung."
24,ALDH3A2,6.406302759387472e-07,False,"Hypertension | Thyroid Neoplasms | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, ALDH3A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ALDH3A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Thyroid Neoplasms | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung."
25,IRAK1,2.08719853844741e-07,False,"Thyroid Neoplasms | Hypertension | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, IRAK1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IRAK1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung."
26,SMARCA4,6.964143040022465e-08,False,"Hypertension | Thyroid Neoplasms | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, SMARCA4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA4, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Thyroid Neoplasms | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung."
27,SMARCA2,2.3315084973773992e-08,False,"Thyroid Neoplasms | Hypertension | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, SMARCA2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Anemia | Neutropenia | Carcinoma, Non-Small-Cell Lung."
28,SCNN1B,7.680964309031424e-09,False,"Thyroid Neoplasms | Hypertension | Carcinoma, Non-Small-Cell Lung | Anemia | Neutropenia",,"Path 1: No (Pralsetinib, inhibits, SCNN1B) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SCNN1B, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Carcinoma, Non-Small-Cell Lung | Anemia | Neutropenia."
29,FXR1,2.5672124426279197e-09,False,"Thyroid Neoplasms | Hypertension | Carcinoma, Non-Small-Cell Lung | Lung Diseases | Anemia",,"Path 1: No (Pralsetinib, inhibits, FXR1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FXR1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Carcinoma, Non-Small-Cell Lung | Lung Diseases | Anemia."
30,ATP1A2,8.694692188448983e-10,False,"Thyroid Neoplasms | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung Diseases",,"Path 1: No (Pralsetinib, inhibits, ATP1A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ATP1A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung Diseases."
31,BCAM,2.9882760155253147e-10,False,"Thyroid Neoplasms | Neoplasms, Glandular and Epithelial | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung",,"Path 1: No (Pralsetinib, inhibits, BCAM) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BCAM, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Neoplasms, Glandular and Epithelial | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung."
32,KNTC1,1.0432431307716428e-10,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms",,"Path 1: No (Pralsetinib, inhibits, KNTC1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KNTC1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms."
33,VASP,3.649263183302942e-11,False,"Thyroid Neoplasms | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung Diseases",,"Path 1: No (Pralsetinib, inhibits, VASP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (VASP, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid Neoplasms | Hypertension | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung Diseases."
34,PDLIM4,1.3010360150333966e-11,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms",,"Path 1: No (Pralsetinib, inhibits, PDLIM4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PDLIM4, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms."
35,CSRP3,4.734029574599008e-12,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms",,"Path 1: No (Pralsetinib, inhibits, CSRP3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CSRP3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms."
36,CPT1A,1.7521842267040344e-12,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms",,"Path 1: No (Pralsetinib, inhibits, CPT1A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CPT1A, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Lymphoma, B-Cell | Carcinoma in Situ | Triple Negative Breast Neoplasms."
37,IDH3A,6.37735632531833e-13,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Lymphoma, B-Cell | Carcinoma in Situ",,"Path 1: No (Pralsetinib, inhibits, IDH3A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (IDH3A, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Lymphoma, B-Cell | Carcinoma in Situ."
38,SELENOP,2.3039439822104824e-13,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Lymphoma, B-Cell | Carcinoma in Situ",,"Path 1: No (Pralsetinib, inhibits, SELENOP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SELENOP, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Lymphoma, B-Cell | Carcinoma in Situ."
39,NUP153,8.394200861749218e-14,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, NUP153) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NUP153, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
40,CLK3,3.137359892279451e-14,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, CLK3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLK3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
41,ACADVL,1.1473287428356415e-14,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, ACADVL) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ACADVL, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
42,CEBPA,4.1591553877166906e-15,False,"Vascular Diseases | Leukemia, Promyelocytic, Acute | Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms",,"Path 1: No (Pralsetinib, inhibits, CEBPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CEBPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: Vascular Diseases | Leukemia, Promyelocytic, Acute | Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms."
43,PRIM2,1.5250040474672733e-15,False,Wilms Tumor | Autoimmune Diseases | Small Cell Lung Carcinoma | Hepatic Insufficiency | Thyroid Diseases,,"Path 1: No (Pralsetinib, inhibits, PRIM2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRIM2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Wilms Tumor | Autoimmune Diseases | Small Cell Lung Carcinoma | Hepatic Insufficiency | Thyroid Diseases."
44,PPM1F,5.605662456742185e-16,False,"Endometrial Neoplasms | Lung Diseases, Obstructive | Breast Neoplasms | Edema, Cardiac | Gallbladder Neoplasms",,"Path 1: No (Pralsetinib, inhibits, PPM1F) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PPM1F, associated_with, outcome) edges in KG. GNN top predicted outcomes: Endometrial Neoplasms | Lung Diseases, Obstructive | Breast Neoplasms | Edema, Cardiac | Gallbladder Neoplasms."
45,CENPA,2.071053392505194e-16,False,"Adenocarcinoma of Lung | Thyroid Dysgenesis | Cardiac Output, Low | Lung agenesis | Kidney Neoplasms",,"Path 1: No (Pralsetinib, inhibits, CENPA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CENPA, associated_with, outcome) edges in KG. GNN top predicted outcomes: Adenocarcinoma of Lung | Thyroid Dysgenesis | Cardiac Output, Low | Lung agenesis | Kidney Neoplasms."
46,DNPH1,1.760337355255083e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, DNPH1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DNPH1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
47,HTATSF1,1.7532871294581711e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, HTATSF1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (HTATSF1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
48,SYT7,1.751381967071339e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, SYT7) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SYT7, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
49,RGS14,1.7016276487963152e-16,False,"Carcinoma, Merkel Cell | Carcinoma, Papillary | Cardiac Conduction System Disease | Leukemia, Experimental | Leukemia L1210",,"Path 1: No (Pralsetinib, inhibits, RGS14) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RGS14, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Merkel Cell | Carcinoma, Papillary | Cardiac Conduction System Disease | Leukemia, Experimental | Leukemia L1210."
50,XRCC2,1.6559564263737516e-16,False,"Renal Insufficiency, Chronic | Urogenital Neoplasms | Hypertension, Malignant | Anemia, Hemolytic | Immune System Diseases",,"Path 1: No (Pralsetinib, inhibits, XRCC2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (XRCC2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Renal Insufficiency, Chronic | Urogenital Neoplasms | Hypertension, Malignant | Anemia, Hemolytic | Immune System Diseases."
51,RRP9,1.6017052895910938e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, RRP9) edge in KG; GNN predicts link (score=0.0000). Path 2: No (RRP9, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
52,KCNQ2,1.5829059227223766e-16,False,"Lung Neoplasms | Ovarian Neoplasms | Peripheral Vascular Diseases | Leukemia, Monocytic, Acute | Euthyroid Sick Syndromes",,"Path 1: No (Pralsetinib, inhibits, KCNQ2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KCNQ2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Lung Neoplasms | Ovarian Neoplasms | Peripheral Vascular Diseases | Leukemia, Monocytic, Acute | Euthyroid Sick Syndromes."
53,KCNQ3,1.4638313544863471e-16,False,"Hypertension, Pulmonary | Central Nervous System Neoplasms | Hematologic Neoplasms | Neoplasm Recurrence, Local | Leukemia, Lymphocytic, Chronic, B-Cell",,"Path 1: No (Pralsetinib, inhibits, KCNQ3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KCNQ3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension, Pulmonary | Central Nervous System Neoplasms | Hematologic Neoplasms | Neoplasm Recurrence, Local | Leukemia, Lymphocytic, Chronic, B-Cell."
54,AKAP8,1.354339243512826e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, AKAP8) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AKAP8, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
55,BCL2L11,1.3525837677296414e-16,False,"Neuroectodermal Tumors | Pseudotumor Cerebri | Lung Diseases | Acute Lung Injury | Carcinoma, Transitional Cell",,"Path 1: No (Pralsetinib, inhibits, BCL2L11) edge in KG; GNN predicts link (score=0.0000). Path 2: No (BCL2L11, associated_with, outcome) edges in KG. GNN top predicted outcomes: Neuroectodermal Tumors | Pseudotumor Cerebri | Lung Diseases | Acute Lung Injury | Carcinoma, Transitional Cell."
56,KLF4,1.1990407818918743e-16,False,"Leukemia | Testicular Germ Cell Tumor | Adenocarcinoma, Bronchiolo-Alveolar | Carcinoma, Large Cell | Squamous Cell Carcinoma of Head and Neck",,"Path 1: No (Pralsetinib, inhibits, KLF4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (KLF4, associated_with, outcome) edges in KG. GNN top predicted outcomes: Leukemia | Testicular Germ Cell Tumor | Adenocarcinoma, Bronchiolo-Alveolar | Carcinoma, Large Cell | Squamous Cell Carcinoma of Head and Neck."
57,AHCYL1,1.1373225202835778e-16,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, AHCYL1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AHCYL1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
58,CBFA2T2,9.766817292200648e-17,False,"Hypertension | Cholangiocarcinoma | Mammary Neoplasms, Experimental | Pituitary Neoplasms | Carcinoma, Renal Cell",,"Path 1: No (Pralsetinib, inhibits, CBFA2T2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CBFA2T2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension | Cholangiocarcinoma | Mammary Neoplasms, Experimental | Pituitary Neoplasms | Carcinoma, Renal Cell."
59,CRYAB,9.037276417408887e-17,False,"Lung Diseases, Interstitial | Hypertension, Pulmonary | Central Nervous System Neoplasms | Hematologic Neoplasms | Neoplasm Recurrence, Local",,"Path 1: No (Pralsetinib, inhibits, CRYAB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CRYAB, associated_with, outcome) edges in KG. GNN top predicted outcomes: Lung Diseases, Interstitial | Hypertension, Pulmonary | Central Nervous System Neoplasms | Hematologic Neoplasms | Neoplasm Recurrence, Local."
60,GCG,8.927764321751768e-17,False,"Thyroid cancer, follicular | Neoplasms, Experimental | Leukemia | Testicular Germ Cell Tumor | Adenocarcinoma, Bronchiolo-Alveolar",,"Path 1: No (Pralsetinib, inhibits, GCG) edge in KG; GNN predicts link (score=0.0000). Path 2: No (GCG, associated_with, outcome) edges in KG. GNN top predicted outcomes: Thyroid cancer, follicular | Neoplasms, Experimental | Leukemia | Testicular Germ Cell Tumor | Adenocarcinoma, Bronchiolo-Alveolar."
61,COL1A1,8.926197310799346e-17,False,"Urologic Neoplasms | Neovascularization, Pathologic | Neuroectodermal Tumors | Pseudotumor Cerebri | Lung Diseases",,"Path 1: No (Pralsetinib, inhibits, COL1A1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (COL1A1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Urologic Neoplasms | Neovascularization, Pathologic | Neuroectodermal Tumors | Pseudotumor Cerebri | Lung Diseases."
62,ABL1,8.700617216822255e-17,False,Maxillary Sinus Neoplasms | Uveal Neoplasms | Esophageal Neoplasms | Hypertension | Cholangiocarcinoma,,"Path 1: No (Pralsetinib, inhibits, ABL1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ABL1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Maxillary Sinus Neoplasms | Uveal Neoplasms | Esophageal Neoplasms | Hypertension | Cholangiocarcinoma."
63,SLC28A2,8.689339105478462e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, SLC28A2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SLC28A2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
64,APOE,8.616194501760603e-17,False,Renal Insufficiency | Carcinoma | Lung Neoplasms | Ovarian Neoplasms | Peripheral Vascular Diseases,,"Path 1: No (Pralsetinib, inhibits, APOE) edge in KG; GNN predicts link (score=0.0000). Path 2: No (APOE, associated_with, outcome) edges in KG. GNN top predicted outcomes: Renal Insufficiency | Carcinoma | Lung Neoplasms | Ovarian Neoplasms | Peripheral Vascular Diseases."
65,GOT2,8.606963827869003e-17,False,"Hypertension, Pregnancy-Induced | Burkitt Lymphoma | Salivary Gland Neoplasms | Adrenal Insufficiency | Neoplasm Metastasis",,"Path 1: No (Pralsetinib, inhibits, GOT2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (GOT2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Hypertension, Pregnancy-Induced | Burkitt Lymphoma | Salivary Gland Neoplasms | Adrenal Insufficiency | Neoplasm Metastasis."
66,OTC,8.16736431615586e-17,False,"Stomach Neoplasms | Pharyngeal Neoplasms | Lymphoma, T-Cell | Renal hypouricemia | Nose Neoplasms",,"Path 1: No (Pralsetinib, inhibits, OTC) edge in KG; GNN predicts link (score=0.0000). Path 2: No (OTC, associated_with, outcome) edges in KG. GNN top predicted outcomes: Stomach Neoplasms | Pharyngeal Neoplasms | Lymphoma, T-Cell | Renal hypouricemia | Nose Neoplasms."
67,FGG,7.99858506048156e-17,False,"Adrenal Cortex Diseases | Renal Insufficiency, Chronic | Urogenital Neoplasms | Hypertension, Malignant | Anemia, Hemolytic",,"Path 1: No (Pralsetinib, inhibits, FGG) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FGG, associated_with, outcome) edges in KG. GNN top predicted outcomes: Adrenal Cortex Diseases | Renal Insufficiency, Chronic | Urogenital Neoplasms | Hypertension, Malignant | Anemia, Hemolytic."
68,PRPF3,7.873016396518052e-17,False,Salivary Gland Neoplasms | Adrenal Insufficiency | Neoplasm Metastasis | Intracranial Hypertension | Intestinal Neoplasms,,"Path 1: No (Pralsetinib, inhibits, PRPF3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRPF3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Salivary Gland Neoplasms | Adrenal Insufficiency | Neoplasm Metastasis | Intracranial Hypertension | Intestinal Neoplasms."
69,LDHA,7.617817280911152e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, LDHA) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LDHA, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
70,C9,7.462386735089988e-17,False,"Vascular Malformations | Ocular Hypertension | Carcinoma, Merkel Cell | Carcinoma, Papillary | Cardiac Conduction System Disease",,"Path 1: No (Pralsetinib, inhibits, C9) edge in KG; GNN predicts link (score=0.0000). Path 2: No (C9, associated_with, outcome) edges in KG. GNN top predicted outcomes: Vascular Malformations | Ocular Hypertension | Carcinoma, Merkel Cell | Carcinoma, Papillary | Cardiac Conduction System Disease."
71,FNTB,7.330512307880864e-17,False,"Leukemia, Myeloid | Leukemia, Erythroblastic, Acute | Leukemia, Myeloid, Acute | Neoplasms | Vascular System Injuries",,"Path 1: No (Pralsetinib, inhibits, FNTB) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FNTB, associated_with, outcome) edges in KG. GNN top predicted outcomes: Leukemia, Myeloid | Leukemia, Erythroblastic, Acute | Leukemia, Myeloid, Acute | Neoplasms | Vascular System Injuries."
72,CLPTM1,7.194597930560031e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, CLPTM1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CLPTM1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
73,AFP,6.734661025434416e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, AFP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AFP, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
74,GAS2,6.722366474553918e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, GAS2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (GAS2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
75,HAND1,6.620090554895411e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, HAND1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (HAND1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
76,CTIF,6.072017224630026e-17,False,"Lymphoma, T-Cell | Renal hypouricemia | Nose Neoplasms | Anemia, Macrocytic | Death, Sudden, Cardiac",,"Path 1: No (Pralsetinib, inhibits, CTIF) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CTIF, associated_with, outcome) edges in KG. GNN top predicted outcomes: Lymphoma, T-Cell | Renal hypouricemia | Nose Neoplasms | Anemia, Macrocytic | Death, Sudden, Cardiac."
77,PF4,5.778111350311565e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, PF4) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PF4, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
78,NDUFB10,5.532284521917136e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, NDUFB10) edge in KG; GNN predicts link (score=0.0000). Path 2: No (NDUFB10, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
79,TYROBP,5.250925323129879e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, TYROBP) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TYROBP, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
80,TFRC,4.7743511689078614e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, TFRC) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TFRC, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
81,APC2,4.7196824713519874e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, APC2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (APC2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
82,TGFB1I1,4.5607254891433866e-17,False,"Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell | Lymphoma, B-Cell | Carcinoma in Situ",,"Path 1: No (Pralsetinib, inhibits, TGFB1I1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TGFB1I1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell | Lymphoma, B-Cell | Carcinoma in Situ."
83,SMARCA5,4.144358833858901e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, SMARCA5) edge in KG; GNN predicts link (score=0.0000). Path 2: No (SMARCA5, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
84,ECD,4.1160464267246804e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, ECD) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ECD, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
85,PRB2,3.945443403235824e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, PRB2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PRB2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
86,DLGAP3,3.67139019449088e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, DLGAP3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DLGAP3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
87,ZW10,3.429823015378854e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, ZW10) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ZW10, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
88,LATS1,3.401924529423156e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, LATS1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (LATS1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
89,ADCY3,3.241350574553137e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, ADCY3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ADCY3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
90,TMEM50A,3.0949836121398386e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, TMEM50A) edge in KG; GNN predicts link (score=0.0000). Path 2: No (TMEM50A, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
91,MMP1,3.0508502177376844e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, MMP1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (MMP1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
92,STAU1,2.880421563921954e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, STAU1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (STAU1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
93,AP2A1,2.7582539357650168e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, AP2A1) edge in KG; GNN predicts link (score=0.0000). Path 2: No (AP2A1, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
94,FMO5,2.6691930535726577e-17,False,"Granulosa cell tumor of the ovary | Carcinoma, Hepatocellular | Porphyrias, Hepatic | Vascular Remodeling | Inflammatory Breast Neoplasms",,"Path 1: No (Pralsetinib, inhibits, FMO5) edge in KG; GNN predicts link (score=0.0000). Path 2: No (FMO5, associated_with, outcome) edges in KG. GNN top predicted outcomes: Granulosa cell tumor of the ovary | Carcinoma, Hepatocellular | Porphyrias, Hepatic | Vascular Remodeling | Inflammatory Breast Neoplasms."
95,PTBP3,2.6443225449672708e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, PTBP3) edge in KG; GNN predicts link (score=0.0000). Path 2: No (PTBP3, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
96,DYNC1LI2,2.5267168178885637e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, DYNC1LI2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (DYNC1LI2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
97,HERC2,2.4691650650256968e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, HERC2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (HERC2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
98,ZNF292,2.3955349062882694e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, ZNF292) edge in KG; GNN predicts link (score=0.0000). Path 2: No (ZNF292, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
99,CDS2,2.3439914625227426e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, CDS2) edge in KG; GNN predicts link (score=0.0000). Path 2: No (CDS2, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
100,OPN1SW,2.3202560111539007e-17,False,"Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell",,"Path 1: No (Pralsetinib, inhibits, OPN1SW) edge in KG; GNN predicts link (score=0.0000). Path 2: No (OPN1SW, associated_with, outcome) edges in KG. GNN top predicted outcomes: Carcinoma, Lewis Lung | Anemia, Sideroblastic | Bone Neoplasms | Tumor Lysis Syndrome | Lymphoma, Extranodal NK-T-Cell."
